Port-Site Metastasis Following Laparoscopic Surgery by Terence C. Chua et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
11 
Port-Site Metastasis Following 
Laparoscopic Surgery 
Terence C. Chua1, Tristan D. Yan1, 
David L. Morris1 and Paul H. Sugarbaker2 
1Hepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, 
St George Hospital, Sydney 
2Washington Cancer Institute, Washington 
1Australia 
2USA 
1. Introduction 
In the 1990s, laparoscopic surgery became accepted as a standard approach for general 
surgical operations including cholecystectomy (Barkun et al., 1992) and appendectomy 
(Attwood, Hill, Murphy, Thornton, & Stephens, 1992). In these randomized studies, the 
laparoscopic compared to the open approach resulted in decreased length of hospital stay, 
fewer postoperative complications, more rapid return to normal activities with reduced 
analgesic requirements. This was associated with decreased cost of care and also achieved 
superior cosmetic results leading to increased patient satisfaction. Following this, the 
frontier of laparoscopic surgery was pushed further forward through experimentation of 
other complex intraabdominal surgery including colorectal surgery (Milsom, Lavery, 
Church, Stolfi, & Fazio, 1994), bariatric surgery (Cowan, 1992) and more recently 
hepatopancreaticobiliary surgery (Gigot et al., 2002). The growth and expanded role of 
laparoscopic surgery in abdominal operations meant that cancer surgery may now be 
performed using laparoscopy. 
Despite the perioperative advantages, laparoscopic cancer surgery has been highly debated 
and its oncological appropriateness has been questioned. Doubts over the technique 
concerned compromising oncologic principles through loss of the surgeon’s ability to 
perform tactile assessment which could otherwise have been performed in an open surgery. 
It was also thought that with laparoscopic approach may limit the extent of resections. For 
example, in the setting of laparoscopic colon resection, reduced lymph nodes harvested 
from insufficient mesentery may make disease staging inaccurate. Further, there are 
concerns regarding the development of port-site metastasis. 
Port site metastasis was first described by Dobronte and colleagues (Döbrönte, Wittmann, & 
Karácsony, 1978) who described the case of a patient developing local tumor metastases in 
the abdominal wall two weeks after laparoscopy for malignancy and explained that this 
occurred due to infiltration of malignant ascites during needle and trocar insertion into the 
abdominal cavity at the port site. Since this report, there has been extensive publication of 
case reports in the literature, describing this phenomenon in gastrointestinal (Cook & Dehn, 
1996), urological (Chueh, Tsai, & Lai, 2004) and gynaecological malignancies (Sanjuán et al., 
www.intechopen.com
 
Advanced Laparoscopy 
 
138 
2005). This chapter identifies through a literature search the risk of port-site metastasis in 
laparoscopic surgery for cancer and discusses the current understanding to guide practice 
and management.  
2. Incidence of port site metastasis 
It was initially thought that port-site metastasis was associated with advanced malignancy. 
Cook and Dehn reported a rate of five of 46 patients (11%) developing port-site metastasis 
after undergoing laparoscopy and identified that advanced disease with serosal 
involvement of the tumor was associated with the occurrence of this phenomenon (Cook & 
Dehn, 1996). However, port-site metastasis has also been reported in patients undergoing 
colectomy for Duke A tumors (Prasad, Avery, & Foley, 1994). This may have been a result of 
soilage of tumor into the peritoneal cavity during surgery, implantation of circulating tumor 
cells present in the lymphatics and haematogenous system that are transacted as part of 
surgery or trauma during the process of specimen retrieval. 
To ascertain the incidence of port-site metastasis, we undertook a literature review of large 
clinical trials that reported results after an adequate follow-up time to determine the risks of 
its occurrence. As shown in table 1, from the 17 studies reviewed that included 11,027 cancer 
patients undergoing laparoscopic surgery or diagnostic laparoscopy, it appears that the 
port-site metastasis is a rare phenomenon, occurring in less than 2% of patients (COLOR, 
2009; Fleshman et al., 2007; Jayne et al., 2010; Kaiser, Kang, Chan, Vukasin, & Beart, 2004; 
Kim, Park, Joh, & Hahn, 2006; Koffron, Auffenberg, Kung, & Abecassis, 2007; Lacy et al., 
2008; Liang, Huang, Lai, Lee, & Jeng, 2007; Lujan et al., 2009; Martinez, Querleu, Leblanc, 
Narducci, & Ferron, 2010; Miyajima et al., 2009; K. H. Ng et al., 2009; S. M. Ng et al., 2008; 
Rassweiler et al., 2003; Shoup et al., 2002; Song et al., 2010; Zivanovic et al., 2008). In eight 
randomized clinical trials comparing laparoscopic surgery to open surgery for cancer, there 
was no statistical difference in the development of port-site metastasis or wound metastasis 
(COLOR, 2009; Fleshman et al., 2007; Jayne et al., 2010; Kaiser et al., 2004; Lacy et al., 2008; 
Liang et al., 2007; Lujan et al., 2009; S. M. Ng et al., 2008).  
In an international survey of port-site metastasis involving members of the German Society 
of Surgery, Swiss Association for Laparoscopic and Thoracoscopic Surgery and Austrian 
Society of Minimal Invasive Surgery, participants reported 70 of 409 cases (17.1%) of port-
site metastasis in patients undergoing laparoscopic cholecystectomy for gallbladder cancer 
and 19 of 412 cases (4.6%) of port-site metastasis in patients undergoing laparoscopic 
surgery for colorectal cancer (Paolucci, Schaeff, Schneider, & Gutt, 1999). These authors 
further alluded to the association of port-site metastasis and the propensity for 
intraperitoneal spread of cancer. The incidence data reported in this study appears to be 
high when compared to the tabulated studies. It is likely that the high incidence may be an 
effect of the learning curve of laparoscopic cancer surgery during the 1990s era as modern 
data seems to suggest otherwise. 
In summary, it appears from current data that port-site metastasis is a rare occurrence and 
its incidence is unlikely to be more common than wound metastasis when oncologic 
principles are adhered to in the technical performance of laparoscopic surgery. 
3. Hypotheses for port-site metastasis 
There are several mechanisms that have been proposed and studied in an experimental 
setting to investigate the development of port-site metastasis in animal models. Although 
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these in-vivo experiments has provided some mechanisms to explain its occurrence, the 
limitations in the homology of animal models where human cancer cell lines are used due to 
the lack of available native tumor cells and the immunodeficient state of these animal 
models (de Jong & Maina, 2010). Nevertheless, animal models remain a unique opportunity 
to provide in vivo information in translation research. The most commonly discussed 
hypotheses include hematogenous dissemination, wound contamination, effects of 
pneumoperitoneum that including the type of insufflating gas, chimney effect, 
aerosolization, surgical technique and the local immune response. Experiments 
investigating these hypotheses have yielded both positive and negative results and it is 
likely the occurrence of port-site metastasis is multifactorial stemming from a combination 
of these various hypotheses. 
3.1 Hematogenous dissemination 
The concept of hematogenous dissemination goes against the concept of direct spread of 
cancer cells to explain port-site metastasis. The establishment of port-sites for access results 
in tissue trauma and during the healing process, its hyperaemic state, provide a nutrient rich 
environment for tumor growth and may become a sanctuary site of tumor metastasis in 
patients with free circulating tumor cells within the systemic circulation. It has been 
previously shown that tumor cells establish themselves in sites with increased blood supply 
at a greater rate than normal tissues (Murphy et al., 1988). Two studies specifically 
compared the rates of port-site metastasis in a group undergoing intravenous cancer cell 
injection versus intraperitoneal injection in a mice model. Iwanaka et al reported an 
incidence of 0% compared to 63% of port-site metastasis in immature A/J mice undergoing 
intravenous compared to intraperitoneal injection of TBJ-neuroblastoma cells (Iwanaka, 
Arya, & Ziegler, 1998). Brundell et al used male Dark Agouti rats and injected a suspension 
of 105 Dark Agouti mammary adenocarcinoma cells into the internal jugular vein and 
stimulated laparoscopic conditions by a 15 minute period of insufflations and compared the 
port-site metastasis rate in rats who had routine closure of port-sites or in another group 
whom they performed a mid-line laparotomy prior to closure. These authors reported one 
case of port-site metastasis in the laparoscopic group and no wound metastasis in the 
laparotomy group (Brundell, Ellis, Dodd, Watson, & Hewett, 2002). Both these studies 
demonstrate that port-site metastasis occurring through hematogenous dissemination is 
rare, even in the presence of a hyperaemic wound state induced by the mid-line laparotomy 
as performed in the second study. 
3.2 Wound contamination 
The effect of direct wound contamination stems from a variety of reasons. The extraction of 
tumor through a small port-site together with the leakage of CO2 that occurs may induce 
movement of free tumor cells that have an increased propensity to implant  in the 
traumatised tissue of the wound (Tseng et al., 1998). During the surgical procedure, ongoing 
passage and extrication of instruments that are contaminated by tumor material due to the 
dissection process, may also explain its occurrence. Bundell et al studied the mechanism of 
wound contamination through detecting an increased deposition of radiolabeled human 
colon cancer cells that were injected intraperitoneally in trocar site due to contamination, 
demonstrated increased movement of tumor cells with increase in volumes of gas 
insufflations and decreased insufflations pressures leading to an increased contamination of 
trocar and port-sites (S. M. Brundell et al., 2002).  
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3.3 Pneumoperitoneum 
Carbon dioxide is the most commonly used gas for insufflations during laparoscopic 
surgery. It is non-flammable, inexpensive, colourless, readily available and readily absorbed 
(Menes & Spivak, 2000). The effect of insufflating gas to distend the abdomen creates a high 
pneumperitoneal pressure and consequentially stimulate movement of free peritoneal 
tumor cells or may result in sloughing or shedding of tumor cells from viscera into the 
peritoneal cavity (Moreira et al., 2001). Hirabayashi et al further elucidated the effect of 
pneumoperitoneum by using a scanning electron microscope to study the effects of how 
tumor cells disseminate to form port-site metastases after pneumoperitoneum in a nude 
mice model injected with human gastric cancer cells. They found that pneumoperitoneum 
immediately results in peeling and destruction of the muscular layer of the abdominal 
peritoneum, increasing the propensity of tumor cell adhesion at port-sites and subsequently 
healing process occurs leading to scar formation with presence of entrapped tumor cells 
(Hirabayashi et al., 2002). A “chimney effect” that occurs when gas leaks out along the trocar 
has been thought to be implicated in the development of port-site metastases. In an 
experiment to examine this hypothesis, tumor cells at trocar sites were found to be higher 
compared to the control when leakage of carbon dioxide gas along the trocar was permitted 
during a rat animal model injected with CC-531 tumor cells intraperitoneally (Tseng et al., 
1998). However, this may be related to the concentration of the amount of injected 
intraperitoneal tumor cells in the animal model as some other authors have not yielded 
similar results in their experiments to support this theory. Brundell et al demonstrated that 
increasing the tumor cell inoculums resulted in increased deposition of tumor cells on both 
ports and port-sites in a swine model, and further showed that displacement of the ports 
(removing and reinserting) increased the number of tumors cells deposited at port-sites 
(Brundell et al., 2003). Whelan et al failed to show that aerosolization of viable tumor cells in 
either in vivo or in vitro experiments with pressures up to 30 mmHg (Whelan et al., 1996). 
Pneumoperitoneum increases intraabdominal pressure and results in an increased in blood 
flow in the anterior abdominal wall. This has also been thought to increase the risk of port-
site metastasis as the increased circulation provides a favourable medium for growth of 
tumor cells (Yavuz, Rønning, Lyng, Grønbech, & Mårvik, 2003). In addition, the type of gas 
has also been shown to influence the rates of port-site metastasis with helium insufflations 
being the least likely compared to argon and nitrogen that were more likely to be associated 
with port-site metastasis (Gupta, Watson, Ellis, & Jamieson, 2002).  
3.4 Immune response 
Carbon dioxide has been thought to be toxic to lymphocytes in vitro and hence its 
insufflations into the peritoneal cavity may potentially affect the peritoneal cell-mediated 
immunity. Mathew et al demonstrate this in an experiment where adenocarcinoma cells 
were injected in the left upper quadrant of the peritoneal cavity in syngeneic tumor-bearing 
rats and subjected to laparotomy, laparoscopy with carbon dioxide or gasless laparoscopy. 
The authors obtained peritoneal macrophage levels and showed that tumor-bearing rats 
produced significantly less TNG-alpha in vitro during laparoscopy with carbon dioxide 
compared to gasless laparoscopy or laparotomy (Mathew, Watson, Ellis, Jamieson, & Rofe, 
1999). The results of this experiment was replicated by Ost et al who measured TNF-alpha 
levels from peritoneal macrophage in mice subjected to either carbon dioxide 
pneumoperitoneum or laparotomy and showed that peritoneal macrophage TNF-alpha 
secretion was significantly inhibited in mice subjected to carbon dioxide pneumoperitoneum 
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(Ost et al., 2008). In a human experiment, Evard et al sampled blood and peritoneal fluid 
before and after pneumoperitoneum from 16 patients undergoing laparoscopic 
cholecystectomy and measured cytokine levels, lymphocyte vitality and showed that there 
were significant decrease in absolute lymphocyte and cytokine counts during the early 
postoperatively before returning to normal levels (Evrard et al., 1997). This transient 
immunosuppression may facilitate implantation of tumor cells during laparoscopic surgery. 
3.5 Surgical technique  
Arguably, the strongest risk for port-site metastasis would be the surgical technique. 
Anecdotal case series reporting port-site metastasis after laparoscopic surgery have shown a 
decrease in rates of port-site metastasis with experience. In a large animal study of mice 
established with splenic tumors (n=128) who underwent either an open splenectomy or 
laparoscopic -assisted splenectomy, it was shown that the incidence of port-site tumor 
recurrence in the laparoscopic-assisted group decreased significantly with time (Lee, 
Gleason, Bessler, & Whelan, 2000). This was likely the experience in human laparoscopic 
surgery. During the 1990s, there were a large number of case reports describing the 
occurrence of port-site metastasis after laparoscopic surgery. This occurred during the initial 
learning curve of surgeons. However, in contemporary series such as the rates of port-site 
metastasis reported in the trials shown in table 1, port-site metastasis is a rare occurrence 
due to improved handling of tumor laparoscopically, meticulous resection, rinsing of 
instruments and the application of protective measures. Other factors that include suture 
closing of the peritoneum (Agostini et al., 2002) and the type of instruments have also been 
investigated (Nduka, Poland, Kennedy, Dye, & Darzi, 1998). 
4. Clinical significance of port-site metastasis  
The clinical significance of port-site metastasis should be regarded as a sign of locoregional 
recurrence. Although this could manifest as a “drop metastasis” during specimen retrieval, 
it is more compatible that the entry into the peritoneal cavity during laparoscopic surgery 
with insufflations of gas, repeated instrument cannulation of port-sites and tumor dissection 
process that leads to spillage of lymph and blood containing circulating tumor cells makes 
port-site metastasis a condition with high risk for peritoneal carcinomatosis. Z’graggen et al 
in a series of 37 patients undergoing laparoscopic cholecystectomy for unsuspected 
gallbladder cancer reported that all patients developed port -site metastasis as recurrence 
that was associated with peritoneal metastases (Z'graggen et al., 1998). The rate at which 
port-site metastasis develop is likely a factor of the tumor biology. Zivanovic et al reported 
20 of 1694 patients developing port-site metastasis after laparoscopic procedures for 
gynaecologic malignancies and showed that in patients who developed port-site metastasis 
7 months from the laparoscopic procedure had a median survival of 12 months compared to 
37 months for patients who develop port-site metastasis after 7 months (P=0.004) (Zivanovic 
et al., 2008). Therefore, port-site metastasis should be regarded a strong risk factor for 
peritoneal dissemination in addition to other previously described factors that include full 
thickness penetration of tumor through the bowel wall, spillage of tumor from lymphatic 
channels by surgical trauma or free perforation of the tumor (Sugarbaker, 1988). 
Peritoneal dissemination of cancer cells in the peritoneal cavity circulate with peritoneal 
fluid as a transport vector along with gravitational forces and fluid hydrodynamics driving 
the peritoneal circulation resulting in the pelvis and subphrenic spaces being a  
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First 
Author 
Year 
Published
Type of 
Study 
Number of Patients
Tumor 
Origin 
Duration 
of 
Follow-
up 
(Months)
Risk of 
Recurrence 
[Lap / 
Open] 
(%) 
Disease-Free 
Survival [Lap 
/ Open]  (% at 
X-Years) 
Incidence 
of Port-Site 
Metastasis 
[Lap / 
Open] (%) 
Laparoscopic Open
Jayne 
(Jayne et 
al., 2010) 
2010 Randomized 526 268 Colorectal 56 NR 
55 / 58 
(P=0.48) at 5-
years 
1.7 / 0.4 
(P=NR) 
Lujan 
(Lujan et 
al., 2009) 
2009 Randomized 97 96 Rectal 34 NR 
85 / 81 
(P=0.895) at 5-
years 
0 / 0 
(P=NR) 
COLOR 
(COLOR, 
2009) 
2009 Randomized 534 542 Colon 53 
31 / 29 
(P=0.24) 
74 / 76 
(P=0.70) at 3-
years 
1.3 / 0.4 
(P=0.09) 
Lacy (Lacy 
et al., 2008) 
2008 Randomized 111 108 Colon 95 
18 / 29 
(P=0.07) 
84 / 61 
(P=0.0015)  at 
5-years 
1 / 0  
(P=0.65) 
Ng (S. M. 
Ng et al., 
2008) 
2008 Randomized 51 48 Rectal 90 NR 
78 / 74 
(P=0.55) at 5-
years 
0 / 2 
(P=NR) 
Fleshman 
(Fleshman 
et al., 2007) 
2007 Randomized 435 428 Colon 60 
19 / 22 
(P=0.25) 
69 / 68 
(P=0.94) at 5-
years 
0.9 / 0.5 
(P=0.43) 
Liang 
(Liang et 
al., 2007) 
2007 Randomized 135 134 Colon 40 NR 
72 / 68 
(P=0.362) at 5-
years 
0.7 / 0.7 
(P=NR) 
 
Kaiser 
(Kaiser et 
al., 2004) 
2004 Randomized 15 20 Colon 35 
0 / 5 
(P=NR) 
NR 
0 / 0 
(P=NR) 
Martinez 
(Martinez 
et al., 2010) 
2010 Retrospective 1216 - 
Uterine / 
Cervical
49 NR NR 0.4 / - 
Song (Song 
et al., 2010) 
2010 Retrospective 1417 - Gastric 41 3.5 / - 94 / - 0 / - 
Ng (K. H. 
Ng et al., 
2009) 
2009 Retrospective 579 - Rectal 56 23 / - 76 / - 0.7 / - 
Miyajima 
(Miyajima 
et al., 2009) 
2009 Retrospective 1057 - Rectal 30 7 / - NR 0 / - 
Zivanovic 
(Zivanovic 
et al., 2008) 
2008 Retrospective 1694 - 
Gynaeco-
logical 
NR NR NR 1.2 / - 
Koffron 
(Koffron et 
al., 2007) 
2007 
Retrospective 
Matched 
Analysis
300 100 Liver 69 
2 / 3 
(P>0.05) 
NR 0 / NR 
Kim (Kim 
et al., 2006) 
2006 Retrospective 312 - Rectal 30 NR NR 0 / - 
Rassweiler 
(Rassweiler 
et al., 2003) 
2003 Retrospective 1000 - Urological 58 NR NR 0.2 / - 
Shoup 
(Shoup et 
al., 2002) 
2002 Retrospective 1548 - 
Diagnostic 
Upper GI 
Cancers
8 NR NR 0.8 / - 
Table 1. Literature review of major clinical trials reporting the risk of port-site metastasis 
common site for cancer cell implantation (Carmignani, Sugarbaker, Bromley, & 
Sugarbaker, 2003). Peritoneal carcinomatosis when managed with chemotherapy alone is 
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a rapidly progressive disease state characterised by a symptomatic clinical course that 
occurs as a result of the peritoneal tumor masses that leads to abdominal pain and sub-
acute bowel obstruction. In a single centre experience of 349 patients with peritoneal 
carcinomatosis from colorectal cancer, the median survival was 7 months (Jayne, Fook, 
Loi, & Seow-Choen, 2002). A combined modality approach of cytoreductive surgery and 
perioperative intraperitoneal chemotherapy introduced by Dr. Paul Sugarbaker from the 
Washington Cancer Centre has been shown to be effective in managing this locoregional 
recurrence and alter the fulminant natural history of this disease (Sugarbaker, Schellinx, 
Chang, Koslowe, & von Meyerfeldt, 1996). Current results of cytoreductive surgery with 
perioperative intraperitoneal chemotherapy for non-gynaecologic malignancies showed a 
potential for a median survival of 34 months with a corresponding 5-year survival rate of 
37% (Olivier Glehen et al., 2010).  
5. Diagnostic laparoscopy in patients at high risk for port-site metastasis 
Data cited in this manuscript strongly suggests that the benefits of laparoscopic oncologic 
surgery outweigh the risk of port-site metastasis. However, there is a subgroup of patients 
who may profit greatly from diagnostic laparoscopy but who are at increased risk for cancer 
implantation at the trochar site. These are patients with ascites in whom there is a high 
index of suspicion for peritoneal carcinomatosis or peritoneal mesothelioma. Patients to be 
included in this group are those who may have mucinous ascites from a colorectal or 
appendiceal adenocarcinoma, ascites from ovarian cancer, ascites associated with a 
diagnosis of gastric cancer, or ascites from peritoneal mesothelioma. In these high risk 
patients a modification of the diagnostic laparascopic technique should be considered. The 
port-sites should be limited to the midline or limited to sites that can be included as part of 
the abdominal incision. Lateral ports should be avoided except under unusual 
circumstances and are rarely mandatory in this clinical setting – diagnostic laparascopy in 
patients with suspect carcinomatosis. 
6. Management of port-site metastasis 
A simple subcutaneous wide excision of port-site metastasis would constitute a failure of the 
understanding of the mechanism that underlies its occurrence. Owing to the high risk for 
peritoneal carcinomatosis, an extensive clinical work-up comprising of positron emission 
tomography scans and contrast enhanced computed tomography scan should be performed to 
identify for other sites of metastasis. In the absence of distant metastasis, a wide excision of the 
port site together with a laparotomy to survey the peritoneal cavity should be performed. If there 
are evidence of peritoneal seeding, a cytoreductive surgery combined with perioperative 
intraperitoneal chemotherapy should be performed in patients whose demographic and disease 
factors fulfil the selection criteria for treatment. For pseudomyxoma peritonei, a complete 
cytoreduction may achieve 5- and 10-year survival of 87% and 74% respectively (Youssef et al., 
2011 ), a median survival of 53 months and 5-year survival of 47%may be achieved in patients 
with diffuse malignant peritoneal mesothelioma (Yan et al., 2009), a median survival of 30 
months and 5-year survival of 27% for colorectal carcinomatosis (Elias et al., 2010), a median 
survival of 30 months and 5-year survival of 25% for ovarian carcinomatosis (Helm et al., 2010) 
and a median survival of 15 months and 5-year survival of 23% in the setting of a complete 
cytoreduction for gastric carcinomatosis (O. Glehen et al., 2010). 
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7. Conclusion 
Previous reports of an increased clinical incidence of port-site metastasis needs to be re-
evaluated. It appears from current data that the incidence of port-site metastasis is rare and 
is unlikely difference from that of wound metastasis, hence does not negate the benefits of 
laparoscopic cancer surgery. The reduction in incidence may in part be due to adherence to 
oncologic principles during laparoscopic surgery and prevention strategies that include 
port-site protective applications (Seow-Choen, Wan, & Tan, 2009). There may be a 
preponderance for the occurrence of port-site metastasis in malignancies that have a 
propensity for peritoneal dissemination, for example, ovarian cancer, colorectal cancer, 
pancreatic cancer, gastric cancer and appendiceal cancer. Port-site metastasis is a strong risk 
factor for peritoneal dissemination.  An accurate diagnostic work-up should include 
imaging and exploration of the peritoneal cavity to identify peritoneal metastases.  In the 
setting of peritoneal disease, referral to specialized peritoneal surface malignancy centres for 
treatment should be mandatory. 
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